// App-Quantinova.ai

e21557 : Next-generation-sequencing of advanced melanoma: Which genetic alterations have an impact on systemic therapy response?

Researchers

Presenter

  • Andrea Forschner

Principal Investigators

  • Franz J. Hilke

  • Tobias Sinnberg

  • Heike Niessner

  • Thomas K. Eigentler

  • Claus Garbe

  • Olaf Riess

  • Stephan Ossowski

  • Tobias Haack

  • Christopher Schroeder

Medical Centers

  • Department of Dermatology Eberhard-Karls University of Tuebingen, Tuebingen, Germany

  • Institute for Medical Genetics and Applied Genomics University Hospital Tuebingen, Tuebingen, Germany

  • Department of Dermatology Eberhard-Karls University of Tuebingen, Tuebingen, Germany

  • Department of Radiation Oncology, University Hospital Tubingen, Tuebingen, Germany

  • Division of Dermato-oncology, University Hospital of Tubingen, Tubingen, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved